MXPA06001278A - Cosmetic or dermatological composition containing a derivative of glucose and vitamin f and a specific surfactant - Google Patents

Abstract

Topically applicable cosmetic/dermatological compositions suited for improving the condition of human keratin fibers, notably human hair, especially for reducing or stopping loss and/or inducing and/or stimulating growth and/or density thereof, contain a thus effective amount of (a) at least one derivative of glucose and of vitamin F, solubilized in a topically applicable, physiologically acceptable medium therefor which includes (b) at least one nonionic surfactant having a hydrophilic/lipophilic balance (HLB) of greater than 10, (c) at least one C1-C4 alcohol and (d) water.

Description

COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING A DERIVATIVE OF GLUCOSE AND VITAMIN F AND A SURGICAL AGENT SPECIFIC FIELD OF THE INVENTION The subject of the invention is a cosmetic or dermatological composition containing, among others, a glucose and vitamin F 'derivative and a specific surfactant, intended to improve the state of human keratin fibers and particularly to decrease or slow down its fall and / or to induce and / or e.sti ulate its growth. The invention also relates to a cosmetic treatment process designed to stimulate the growth of these human keratin fibers and / or slow down their fall, as well as the use of the combination of the glucose derivative and vitamin F and a surfactant. specific to induce and / or stimulate the growth of these keratin fibers and / or slow their fall. BACKGROUND OF THE INVENTION The human keratin fibers to which the invention is applied are particularly the hair, the eyelashes, the hairs of the beard, the mustache and the pubic hairs. More especially, the invention is applied to human hair and / or eyelashes. Also, more precisely, the invention relates to a physiologically acceptable composition containing a REF .: 169357 derived from glucose and vitamin F and a particular nonionic surfactant, intended to improve the condition of human hair and particularly to induce and / or stimulate hair growth and / or slow down its hair loss. In the human being, hair growth and renewal are mainly determined by the activity of the hair follicles and their dermo-epidermal environment. Its activity is cyclical and essentially comprises three phases, namely the anagen phase, the catagen phase and the telogen phase. To the anagen phase (active phase or growth phase), which lasts several years and in the course of which the hair grows, a very short and transient catagen phase that lasts a few weeks occurs. In the course of this phase, the hair undergoes an evolution, the follicle atrophies and its dermal implantation appears increasingly higher. The terminal phase, which lasts a few months, corresponds to a resting phase, called the telogen phase. At the end of this period of rest, the hair falls and another cycle begins again. The hair is therefore renewed permanently, and of the approximately 150,000 hairs comprising a hair, at each moment, approximately 10% of them are at rest and will therefore be replaced in a few months.

The literature mentions numerous reasons that produce the precocious fall of the hair; in particular, this early fall occurs in genetically predisposed subjects and particularly affects men. It is more particularly about androgenetic or androgenic alopecia or also androgeno-genetic alopecia. This alopecia is essentially due to a disturbance of the capillary renewal that produces, in a first time, the acceleration of the frequency of the cycles to the detriment of the quality of the hair and then its quantity. There is a progressive impoverishment of the hair by regression of the hair called "terminals" in the hair growth phase. There are preferably affected areas; particularly in men, the temporal or frontal gulfs as well as the upper part of the occipital, while in women a diffuse alopecia of the vertex is observed. Other causes can produce an important, temporary or definitive hair loss. It may be a fall and alteration of the hair after a pregnancy (post-partum), in the course of malnutrition or food imbalances or also in the course of asthenia or hormonal dysfunction as may be the case in the course or after menopause. It can also be a fall or alterations of the hair in relation to seasonal phenomena.

BRIEF DESCRIPTION OF THE INVENTION It has been investigated for many years, particularly in the cosmetic industry, compositions that allow to suppress or reduce the effect of alopecia and particularly to induce or stimulate the growth of the hair and / or of certain hair dyes, even to reduce or delay his fall. For this purpose, a very particular new compound, O-acylated glucose derivative, has remarkable properties that justify its use as an active agent to limit hair loss and / or promote its growth; this compound corresponds to the result of the esterification of glucose by vitamin F. Its manufacture is described in the application FR-A-2 840 903 in which compositions containing particularly the glucose derivative and vitamin F in a medium are illustrated. hydroalcoholic The formulation of this derivative in a cosmetic or dermatological composition must respect a certain number of technical obligations in order that it can play, effectively, its role as an active anti-hair loss / growth agent. Thus, this derivative must be perfectly solubilized in the composition. The latter, generally used without rinsing, should be applied easily on the entire part of the scalp to be treated, not cause any irritation and not stick. In addition, the hair that can be impregnated by the composition must maintain a pleasant touch (neither rough, nor greasy, nor sticky ...), a clean and voluminous appearance. DETAILED DESCRIPTION OF THE INVENTION After numerous studies, the applicant has discovered that these technical obligations were solved by formulating this derivative in a composition containing a non-ionic surfactant of hydrophilic-lipophilic balance (HLB) greater than 10 and a Cx alcohol. -C4. The subject of the present invention is therefore a physiologically acceptable composition comprising: (a) at least one glucose and vitamin F derivative, (b) at least one hydrophilic / lipophilic equilibrium nonionic surfactant greater than 10, (c) ) at least one alcohol of C? -C4, and (d) water. This composition is in particular intended to induce and / or stimulate the growth of the keratin fibers and / or slow their fall and / or increase their density. It can be used as such or added to a more complex physiologically acceptable composition. The invention also relates to the use of the combination of at least one glucose derivative and vitamin F, of at least one hydrophilic / lipophilic balance nonionic surfactant greater than 10, of at least one C? -C alcohol and water, in a composition for inducing and / or stimulating the growth of keratin fibers of human beings and / or slowing their fall and / or increasing their density. By increasing the density of the keratin fibers, and particularly the capillary density, it is meant to increase the number of keratin fibers, particularly of hair, per cm 2 of skin such as the scalp. Thus, this composition makes it possible to keep the hair in good condition and / or to fight against the natural fall of the hair, in particular of men. In particular, the invention relates to the cosmetic use of the association of at least one glucose derivative and vitamin F, of at least one hydrophilic / lipophilic balance nonionic surfactant greater than 10, of at least one C alcohol? -C4 and water, in a particularly cosmetic composition for the treatment of human hair, to treat alopecia of natural origin and in particular androgenic alopecia or andro-chrono-genetics, as well as in the use of this association for the preparation of a composition for treatment and / or treatment of the keratin fibers of human beings, and in particular of the hair, intended to induce and / or stimulate the growth of keratin fibers, and in particular of the hair and / or slow down its hair loss and / or increase its density. The subject of the invention is also the cosmetic use of a hair treatment composition for human beings, comprising at least one glucose and vitamin F derivative, at least one non-ionic surfactant of HLB greater than 10, at least one C1-C4 alcohol and water, to reduce hair loss and / or increase its density and / or treat androgenic alopecia. The present invention also has for its object a method of cosmetically treating the human keratin fibers and / or the skin from which the above mentioned fibers emerge, in particular the scalp, particularly intended to stimulate growth. of the aforementioned human keratin fibers, in particular the hairs and some hairs of human beings, and / or restraining their fall, characterized by the fact that it consists of applying on these human keratin fibers and / or the skin from which they emerge. fibers, a cosmetic composition as defined above, in contact with these keratinous fibers and / or the skin from which these fibers emerge, and eventually in clarifying these keratinous fibers and / or said skin. This treatment process has the characteristics of a cosmetic procedure insofar as it improves the aesthetics of the keratin fibers and in particular of the hair and eyelashes of human beings, giving them a greater vigor and an improved appearance.

In addition, it can be used daily for several months, without medical prescription. More particularly, the subject of the present invention is a method of cosmetic treatment of the hair and / or scalp of human beings, with a view to improving their condition and / or appearance, characterized in that it consists of applying to the hair and / or or the scalp of human beings, a cosmetic composition as defined above, in leaving this in contact with the hair and / or the scalp, and eventually in lightening the hair and / or the scalp. DETAILED DESCRIPTION OF THE MODALITIES OF THE INVENTION According to the invention, "at least one" means one or more (2, 3 or more). In particular, the composition may contain one or more derivatives of glucose and vitamin F. In the rest of the text, and unless otherwise indicated, the amounts of the different ingredients of the composition are given in percentage by weight with respect to the total weight of the composition. Essential raw materials for the invention Derivative of glucose and vitamin F: The derivative of glucose and of vitamin F is a 0-acylated derivative obtained by partial or total esterification of vitamin F by glucose, whose manufacture is described in the document EP-A-1371658. This derivative can be represented by a compound of the following formula (I) or a mixture of compounds of formula (I): • in which Rlf R2, R, R4 and 5, independently of one another, represent hydrogen or a radical -CO-R representing R a linear, saturated or unsaturated hydrocarbon chain, comprising from 11 to 21 carbon atoms , with the proviso that at least one of the radicals Rx to R5 is different from hydrogen. In particular, the glucose and vitamin F derivative comprises a mixture of mono- or di-ester fatty acids of Cis-Cia. The fatty acid is in particular selected from linoleic acid, oleic acid, palmitic acid, stearic acid and mixtures thereof. This derivative of glucose and vitamin F is particularly chosen from the compounds 6-O-octadeca-9-enoyl-D-glucopyranose, 6-O-hexadecanoyl-D-glucopyranose, 6-0-octadeca-9, 12-dienoyl- D-glucopyranose, 6-O-octadecanoyl-D-glucopyranose, 3-0-octadeca-9, 12-dienoyl-D-glucopyranose, their mixtures. The derivative is in particular the ester of glucose and of vitamin F, mostly esterified in position 6, obtained according to example 1 of EP-A-1371658.

The amount of glucose derivative and vitamin F, used, corresponds to the amount necessary to obtain the desired result (in particular to increase the density of the keratin fibers or to promote their growth). The person skilled in the art is therefore in a position to evaluate this effective amount which depends on or of. the derivatives used, the person to whom it is applied, and the time of this application. To provide an order of magnitude, in the composition according to the invention, the vitamin F and glucose derivative or the mixture of vitamin F derivatives and glucose can be used in an amount representing from 0.01% to 10% by weight. weight, preferably from 0.05% to 5% by weight and more preferably from 0.1% to 2% by weight. Nonionic surfactant: The composition according to the invention may contain one or more nonionic surfactants with a hydrophilic-lipophilic balance (HLB) greater than 10 (see GRIFFIN, W.C. J.

Soc. Cosmet. Chem. 1949, 1, 311. and 1954, 5, 249.) and that can reach up to 20; they are well-known compounds themselves (see particularly in this regard "Handbook of Surfactants "by M.R. PORTER, Editions Blackie & Son (Glasgow and London), 1991, pages 116-178). Thus, they can be particularly chosen from alcohols, alpha-diols, alkyl (C? -C2o) phenols or fatty acids, polyethoxylated, polypropoxylated or polyglycerolated, particularly hydrogenated, with a fatty chain comprising, for example, from 8 to 22 carbon atoms (particularly from 12 to 18), the average number of groups of ethylene oxide or propylene oxide, in particular from 3.5 to 200 (for example from 5 to 100) and the number of glycerol groups may vary, particularly between 2 and 100 (for example, between 3 and 50), their mixtures. Mention may also be made of copolymers of ethylene oxide and propylene oxide, condensates of ethylene oxide and propylene oxide on fatty alcohols.; the polyethoxylated fatty amides and preferably those having on average 3.5 to 200 moles of propylene oxide and / or ethylene (for example 5 to 100); the polyglycerolated fatty amides and preferably those having on average from 1.5 to 40 glycerol groups and in particular from 1.5 to 25; ethoxylated sorbitan fatty acid esters having in particular from 2 to 30 moles on average of ethylene oxide and a fatty chain having in particular from 8 to 22 carbon atoms (for example from 12 to 18); the fatty acid esters of sucrose; fatty acid esters of polyethylene glycol; the alkyl (C6-C24) polyglycosides; the N-alkyl (Ce-C24) glutamine derivatives; the amine oxides such as the oxides of (C 10 -C 14) alkylamines; and its mixtures. By fatty acids, mono- or polyacid acids are understood to have from 8 to 22 carbon atoms and better from 12 to 18 atoms. According to one embodiment, a non-ionic surfactant of HLB greater than 10 one or more surfactants selected from alcohols, alpha-diols, alkyl (C 1 -C 20) phenols or polyethoxylated, polypropoxylated or polyglycerolated fatty acids is used. , hydrogenated having a fatty chain comprising from 8 to 18 carbon atoms, the average number of ethylene oxide or propylene oxide groups ranging from 3.5 to 200 and the number of glycerol groups ranging from 2 to 100, its mixtures The nonionic surfactant or the mixture of nonionic surfactants, of HLB greater than 10, is preferably used in an amount sufficient to solubilize the vitamin F derivative and glucose with the alcohol. Its content is therefore based on the content of vitamin F derivative and glucose. In practice, this nonionic surfactant or mixture of nonionic surfactants can be used in the composition of the invention, with a concentration ranging between 0.01% and 10% by weight, preferably between 0.05% and 5% by weight and more preferably between 0.1% and 2% by weight.

Alcohol: Can be used alone or as a mixture and is chosen from C3-C4 alcohols such as ethanol or isopropanol, their mixtures. The C1-C alcohol or the mixture of C1-C4 alcohols is preferably used in an amount sufficient to solubilize with the non-ionic surfactant the vitamin F derivative and glucose. Its content is therefore dependent on the content, in vitamin F derivative and glucose. In practice, the C1-C4 alcohol or the mixture of C3-C4 alcohols can be used in the composition of the invention at a concentration ranging from 2% to 80% of the total weight of the composition, preferably between a % and 70% of the total weight of the composition and more preferably between 20% and 60% by weight. The composition of the invention can be of cosmetic or pharmaceutical use. Preferably, the composition of the invention is of cosmetic use and in particular of topical application on the skin and keratin fibers, and more especially on the scalp, hair and eyelashes of human beings. Also, the composition must contain a physiologically acceptable non-toxic medium capable of being applied to the skin, including the scalp and eyelids, and the keratin fibers of human beings.

This composition can be presented in any known galenic form adapted to the mode of use. Non-essential raw materials for the invention Galenic form: For a topical application on the skin, including the scalp, the composition may take the form of a solution, a suspension, an emulsion or dispersion of more or less fluid consistency and particularly liquid or semi-liquid, obtained by dispersing a fatty phase in a phase - aqueous (H / E) or vice versa (E / H), or also, of a gel. It is also possible to consider a composition in the form of a foam or also in the form of a spray or an aerosol comprising a propellant under pressure. In particular, the application composition on the scalp or the hair may be in the form of a hair treatment lotion, for example of daily or bihebdomadarial application, of a shampoo or of a product after washing with capillary shampoo, in particular of bihebdomadaria or hebdomadaria application, of a liquid or solid cleaning soap of the daily application of the scalp, of a styling product (lacquer, marking product, combing gel), of a treating mask, a cream or a foaming gel of cleaning the hair. It can also be presented in the form of dye or capillary mask to be applied with a brush or a comb. On the other hand, for an application on the eyelashes or hairs, the composition to which the invention is applied can be presented in the form of a mask, pigmented or not, to be applied with the brush on the eyelashes or also on the hairs of the beard or the mustache. According to a particular embodiment, the composition according to the invention is in the form of a cream or hair lotion, of shampoo or of a product after washing with capillary shampoo, of mascara for, of hair or for eyelashes. The amounts of the different constituents of the physiological medium of the composition according to the invention are generally those used in the areas considered. In addition, these compositions are prepared according to the usual methods. When the composition is an emulsion, the proportion of the fatty phase can range between 2% and 80% by weight, and preferably between 5% and 50% by weight relative to the total weight of the composition. The aqueous phase is adjusted according to the content in fat phase, in vitamin derivative F and glucose, in alcohol and non-ionic surfactant as well as any additional ingredients, to obtain 100% by weight. In practice, the aqueous phase represents from 5% to 89.9% by weight.

The fatty phase may contain oily or fatty compounds, liquids at room temperature. (25 C) and atmospheric pressure (760 mm Hg), generally called oils, waxes and pasty or semi-solid products. These oils can be compatible with each other and form a macroscopically homogeneous liquid fatty phase. The aqueous phase contains water and optionally a water-insoluble ingredient such as polyols such as propylene glycol, glycerol or sorbitol Formulation additives The composition of the invention may further comprise one or more other ingredients usually used in the preparation. the areas in question, selected among the formulation additives such as thickeners or gelling agents of aqueous phase or oily phase, dyes soluble in the medium of the composition, solid particles of type fillers or pigments, mineral or organic in the form of micro or nano particles, preservatives, perfumes, hydrotropes or electrolytes, neutralizers (alkalizing or acidifying), propellants, anionic, cationic or amphoteric surfactants, particularly smoke-forming, anionic, non-ionic, cationic or hydrolysable or water-dispersible amphoters, mineral or organic salts, chelating agents s; its mixtures These additives can be present in the composition according to the amounts generally used in the cosmetic and dermatological field and particularly in a proportion of 0.01 to 50% of the total weight of the composition and better of 0.1 to 20% and for example from 0.1, to 10%. Of course, the person skilled in the art will try to select the complementary optional ingredients and / or their quantity in such a way that the advantageous properties of the composition according to the invention, particularly namely the increase in the density of the keratin fibers, are not substantially , altered by the considered addition. As oils which can be used in the invention, oils of mineral origin (petrolatum oil, hydrogenated isoparaffin), oils of vegetable origin (liquid fraction of charcoal butter, sunflower, apricot, soybean, alcohol or acid oil) may be mentioned. fatty), oils of animal origin (perhydrosqualene), synthetic oils (fatty acid esters, Purcellin oil), silicone oils (linear or cyclic polydimethylsiloxanes, phenyltrimethicones) and fluorinated oils (perfluoropolyethers). As waxes, silicone waxes, beeswax, candelilla, rice, carnauba or paraffin or polyethylene waxes can be mentioned. When the composition is in the form of an emulsion, it also contains one or more emulsifiers and optionally one or more co-emulsifiers generally used in the cosmetic and pharmaceutical fields. Its nature is also a function of the sense of emulsion. In practice, the emulsifier and optionally the co-emulsifier are present, in the composition, in a proportion ranging from 0.1% to 30% by weight, preferably between 0.5 and 20% by weight and better between 1 and 8% The emulsion may also contain lipid vesicles and particularly liposomes. As a thickener or gelling agent which can be used in the invention, mention may be made of thickener or gelling polymers such as crosslinked polyacrylic acids, associative polymers and non-polymeric thickeners or gelling agents, such as modified or non-modified clays, amides, metal salts of fatty acids. Cosmetic and pharmaceutical active agents The composition of the invention may further comprise one or more cosmetic and pharmaceutical active agents of beneficial action for the skin, and particularly for the scalp, and keratin fibers (other than vitamin F derivative and glucose). As active cosmetic or pharmaceutical active agent for hair or scalp, which can be used in the invention, the active agent (s) selected from among: U.V. blocking agents can be mentioned. such as sunscreens; - the vitamins (A, C, E) and their derivatives (ret. palmitate, acetate or tocopherol palmitate); - the ceramides; - the proteins and their hydrolysates, the peptides, the ined acids (natural); - urea, allantoin; sugars and sugar derivatives such as reduced or oxidized sugars; - extracts of plant origin (those of Iridáceas or of soybean) or bacterial; hydroxy acids in particular hydroxycarboxylic or ketocarboxylic acids (fruit acid, salicylic acid) and their esters such as n-octanoyl-5-salicylic acid, - diazoxide, spiroxasone, phospholipids such as particularly deoiled lecithin. - Additional active compounds that promote growth and / or limit the hair loss, such as, in particular: the nicotinic acid esters, of which, in particular, tocopherol nicotinate, benzyl nicotinate and alkyl nicotinates. C -C 1 22 such as methyl or hexyl nicotinates; pyrimidine derivatives, such as 2,4-diamino-6-piperidinopyrimidine 3-oxide or "minoxidil" described in patents US 4139619 and US 4592812; pyrimidine 3-oxide derivatives such as those described in WO 92/01437 or WO 96/09048, and particularly the "aminoexil" or 2,4-diaminopyrimidine 3-N-oxide, the antiandrogens as the steroid or non-steroidal inhibitors of 5a-reductase, such as the finaesteride and the compounds described in US 5 516779, the cyproesterone acetate, the azelaic acid, its salts and its derivatives and the compounds described in US 5 480 913, the flutamide and the compounds described in the US patents 5 411981, 5 565467 and 4 9-10226, protaglandins such as PGF2-a or PGE2 in the form of salt or esters, and their analogues such as latanoprost; - Antibacterial or antifungal or antipelicular agents such as selenium derivatives, ketoconazole , octopirox, triclocarban, triclosan, zinc pyrithione, itraconazole, asiatic acid, hinoquitiol, mipirocin, tetracyclines, particularly erythromycin and the compounds described in EP 0680745, the clinicalin hydrochloride, benzoyl or benzyl peroxide and minocycline; - Calcium channel antagonists and potassium channel agonists; - The hormones; - Steroid anti-inflammatory agents such as glucocorticoids, corticosteroids (for example: hydrocortisone) and non-steroidal anti-inflammatories such as glycyrrhetinic acid and a-bisabolol, benzydamine and the compounds described in? P 0770399, WO 94 / 06434 and FR 2268523; The agonists of the RXR receptors of the retinoids and the antagonists of the retinoids; - Anti-free radical agents and antioxidants such as Butyl-Hydroxy-Anesol or Butyl-Hydroxy-Toluene; - The anti-seborrheic; - Antiparasitics; - Antivirals; - The antipruritic; - Carotenoids such as ß-carotene; - Lactones and their corresponding salts: Essential fatty acids such as linoleic, eicosatetraenoic, linolenic, and eicosatrienic acids or their esters and amides; - Essential oils; - Phenols and polyphenols such as flavonoids; - Your mixtures. According to a preferred embodiment of the invention, the composition also contains an additional active agent that promotes growth and / or limits the hair loss and in particular minoxidil, aminoexil, latanoprost or their mixtures. This additional active agent can be present in an amount effective to reduce hair loss and / or limit its fall and / or increase its density and for example with a content of 0.001% to 10% by weight, preferably 0.1 % to 5% and better from 0.5% to 3%.

EXAMPLES Demonstration (a) The following 4 compositions were made (in grams): Composition A B C D Derived from vitamin F 5 5 5 5 and glucose * PEG 40 Beaver Oil 3 3 hydrogenated Ethanol 24.6 24.6 42.4 42.4 Water csp 100 csp 100 csp 100 csp 100 Appearance of the Milky limpid limpid composition (TO) Appearance of the Milky limpid limpid composition (J0 + 1) * obtained according to example 1 of EP-A-1371658.

These tests perfectly illustrate the role of the nonionic surfactant on the solubility of the active agent. (b) 1 ml of the freshly prepared compositions B, C, D are applied separately to three wicks of 2.5 g natural hair.

In the application, the wick treated with the composition C is very rough and unravels hardly. The wicks treated with compositions B and D are soft and easily unravel. After drying, the feel and appearance of the hair treated with the compositions B and D are better than with the composition C. They have a smooth feel, and are easily disentangled without developing static electricity and are bright. These tests illustrate the beneficial effect of the surfactant on the cosmetic properties of the hair. Example of composition according to the invention A serum was made which has by composition: Derived of vitamin F and glucose * 0.1 g Aminoexil 1.5 g PEG 40 Hydrogenated Castor Oil (HLB13) 0.1 g Ethanol 47.2 g Water csp 100 g The composition comes in the form of a colorless fluid lotion perfectly transparent. It is applied with great ease on the scalp, distributing easily. It dries quickly without adding discomfort. The hair impregnated by the composition are soft and smooth.

It is noted that in relation to this date, the best method known to the applicant to carry out the aforementioned invention, is that which is clear from the present description of the invention.

Claims (23)

1. R E I V I N D I C A C I O N S Having described the invention as above, the content of the following claims is claimed as property: 1. Physiologically acceptable composition, characterized in that it comprises: (a) at least one glucose and vitamin F derivative, (b) at least one hydrophilic / lipophilic balance nonionic surfactant (HLB) greater than 10, (c) at least one C? -C4 alcohol, (d) water. Composition according to claim 1, characterized in that the glucose and vitamin F derivative is an O-acylated derivative obtained by partial or total esterification of vitamin F by glucose. Composition according to one of the preceding claims, characterized in that the glucose and vitamin F derivative is used in an amount representing from 0.01% to 10% of the total weight of the composition. Composition according to one of the preceding claims, characterized in that the glucose and vitamin F derivative is used in an amount representing from 0.1% to 2% of the total weight of the composition. Composition according to one of the preceding claims, characterized in that the non-ionic surfactant of HLB greater than 10 is selected from alcohols, alkylaryl, alkyl (C? -C2o) phenols or polyethoxylated, polypropoxylated fatty acids or polyglycerbols, copolymers of ethylene oxide and propylene oxide, condensates of ethylene oxide and propylene oxide on fatty alcohols; the polyethoxylated fatty amides; the polyglycerolated fatty amides; esters of sorbitan fatty acids ethoxylated; the fatty acid esters of sucrose; fatty acid esters of polyethylene glycol; the alkyl (C5-C24) polyglycosides; the N-alkyl (C3-C24) glutamine derivatives; the amine oxides; and its mixtures. 6. Composition according to one of the preceding claims, characterized in that the non-ionic surfactant of HLB greater than 10 is selected from alcohols, alkylaryl, (C 1 -C 20) alkyl phenols or polyethoxylated, pslipropoxylated or polyglycerolated fatty acids, hydrogenated having a fatty chain comprising from 8 to 18 carbon atoms, the average number of ethylene oxide or propylene oxide groups ranging from 3.5 to 200 and the number of glycerol groups ranging from 2 to 100, their mixtures . 7. Composition according to one of the preceding claims, characterized in that the nonionic surfactant or the mixture of nonionic surfactants, of HLB greater than 10, is used in sufficient quantity to solubilize with the alcohol the vitamin F derivative and glucose . Composition according to one of the preceding claims, characterized in that the nonionic surfactant or the mixture of nonionic surfactants, of HLB greater than 10, is used at a concentration ranging from 0.01% to 10% of the total weight of the composition. Composition according to one of the preceding claims, characterized in that the nonionic surfactant or the mixture of nonionic surfactants, of HLB greater than 10, is used at a concentration ranging from 0.1% to 2% of the total weight of the composition. 10. Compliance composition. with one of the preceding claims, characterized in that the C?-C 4 alcohol is selected from ethanol or isopropanol, their mixtures. Composition according to one of the preceding claims, characterized in that the C 1 -C 4 alcohol or the mixture of these alcohols is used at a concentration of 2% to 80% of the total weight of the composition. Composition according to one of the preceding claims, characterized in that the C 1 -C 4 alcohol or the mixture of these alcohols is used at a concentration of 20% to 60% of the total volume of the composition. 13. Composition according to one of the preceding claims, characterized in that the composition is presented in the form of a cream or a hair lotion, a shampoo or a product after washing with hair shampoo, a mask for hair or for eyelashes. 14. Composition according to one of the preceding claims, characterized in that it comprises one or several other ingredients selected from the thickeners or gelling agents of aqueous phase or oily phase, the coloring matters soluble in the medium of the composition, the fillers and the pigments, mineral or organic in the form of micro- or nanoparticles, preservatives, perfumes, hydrotropes, electrolytes, neutralizers, propellants, anionic, cationic or amphoteric surfactants, smoke-forming, anionic polymers, non-ionic, cationic or amphoteric water-soluble or water-dispersible, mineral or organic salts, chelating agents; its mixtures Composition according to one of the preceding claims, characterized in that it comprises one or more cosmetic or pharmaceutical active agents with beneficial action for the hair or the scalp selected from the U.V. blocking agents; vitamins and their derivatives; the ceramides; the proteins, their hydrolysates, the peptides, the amino acids; the urea, the alantóina; sugars and sugar derivatives; extracts of plant or bacterial origin; the hydroxy acids and their esters; diazoxide, spiroxasone, phospholipids; the nicotinic acid esters; minoxidil; the aminoexil; steroid or non-steroidal inhibitors of 5a-red ctasa; antibacterial, antifungal or antipelicular agents; the calcium channel antagonists; the potassium channel agonist agents; the hormones; the steroidal and non-steroidal anti-inflammatory agents; the RXR receptor agonists of the retinoids and the retinoid antagonists; anti-free radical agents and antioxidants; the antiseborrheic; the antiparasitics; the antivirals; the antipruritic, the carote oides; the lactoses and their corresponding salts; the essential fatty acids or their esters and amides; the essential oils; phenols and polyphenols, their mixtures. 16. Composition according to one of the preceding claims, characterized in that it also comprises an additional active agent that favors growth and / or limits the fall of the hair. Composition according to one of the preceding claims, characterized in that it also comprises an additional active agent that favors growth and / or limits the fall of the. Hair selected from minoxidil, aminoexil, latanoprost or their mixtures. 18. Cosmetic use of the combination of at least one glucose derivative and vitamin F, at least one hydrophilic / lipophilic balance non-ionic surfactant greater than 10, at least one C? -C4 alcohol and water, in a cosmetic composition for inducing and / or stimulating the growth of human keratin fibers and slowing their fall and / or increasing their density. 19. Use of the combination of at least one glucose derivative and vitamin F, at least one hydrophilic / lipophilic balance nonionic surfactant higher than 10 and at least one C? -C alcohol and water, for the preparation of a composition for treatment and / or treatment of human keratin fibers, intended to induce and / or stimulate the growth of human keratin fibers and / or slow their fall and / or increase their density. 20. Cosmetic use of the association of at least one glucose derivative and vitamin F, of at least one non-ionic surfactant of HLB greater than 10, of at least one C? -C alcohol and of water, in one composition of hair treatment of the human being to reduce hair loss and / or increase its density and / or treat androgenic alopecia. 21. Use of the association of at least one glucose derivative and vitamin F, at least one non-ionic surfactant of HLB greater than 10, of at least one Cx-C4 alcohol and of water, for the preparation of a hair composition for human beings, intended to induce and / or stimulate the growth of the hair and / or restrain its fall and / or increase its density and / or treat androgenic alopecia. Process for the cosmetic treatment of human keratin fibers and / or skin, where the fibers emerge, in particular the scalp, intended particularly to stimulate the growth of human keratin fibers, in particular the hair and some hairs of human beings and / or slowing down its fall, characterized in that it consists of applying to the human keratin fibers and / or the skin from which these fibers emerge, a cosmetic composition according to one of claims 1 to 18, in contact with these keratin fibers. and / or the skin from which these fibers emerge, and eventually to clear these keratin fibers and / or the indicated skin. Method for the cosmetic treatment of the human hair and / or scalp, in order to improve its condition and / or its appearance, characterized in that it consists in applying a cosmetic composition in accordance with the human hair and / or scalp to the hair. one of claims 1 to 18, leaving it in contact with hair and / or the scalp, and eventually in lightening the hair and / or the scalp.